Zhuo‐Xun Wu

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer

Lei Zhang, Yidong Li, Qianchao Wang et al. · Molecular Cancer · 2020 · 170 citations · Full text

Medicine, Oncology, Pharmacology +13

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression

Zhenzhen Pan, K. Wang, Xiniao Wang et al. · Molecular Cancer · 2022 · 148 citations · Full text

Medicine, Oncology, Pharmacology +16

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer

Zhenduo Shi, Lin Hao, Xiaoxiao Han et al. · Molecular Cancer · 2022 · 128 citations · Full text

Medicine, Molecular Biology, Oncology +17

Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells

Zhuo‐Xun Wu, Qiu‐Xu Teng, Chao‐Yun Cai et al. · Biochemical Pharmacology · 2019 · 70 citations

Medicine, Oncology, Pharmacology +14

Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells

Zi‐Ning Lei, Qiu‐Xu Teng, Zhuo‐Xun Wu et al. · MedComm · 2021 · 51 citations · Full text

Medicine, Oncology, Pharmacology +13